According to Inovio Pharmaceuticals's latest financial reports the company's current revenue (TTM) is $0.83 M. In 2022 the company made a revenue of $10.26 M an increase over the years 2021 revenue that were of $1.77 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.83 M | -91.89% |
2022 | $10.26 M | 478.24% |
2021 | $1.77 M | -76.05% |
2020 | $7.41 M | 80.24% |
2019 | $4.11 M | -86.51% |
2018 | $30.48 M | -27.8% |
2017 | $42.22 M | 19.37% |
2016 | $35.36 M | -12.83% |
2015 | $40.57 M | 288% |
2014 | $10.45 M | -22.35% |
2013 | $13.46 M | 226.98% |
2012 | $4.11 M | -57.95% |
2011 | $9.79 M | 59.41% |
2010 | $6.14 M | -32.62% |
2009 | $9.12 M | 334.78% |
2008 | $2.09 M | -56.37% |
2007 | $4.8 M | 38.62% |
2006 | $3.46 M | -36.56% |
2005 | $5.46 M | 368.45% |
2004 | $1.16 M | 1349.29% |
2003 | $0.08 M | -57.51% |
2002 | $0.18 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | 11,180,281.03% | ๐บ๐ธ USA |
Novartis NVS | $49.92 B | 6,000,301.44% | ๐จ๐ญ Switzerland |
Pfizer PFE | $58.49 B | 7,030,696.47% | ๐บ๐ธ USA |
Gilead Sciences GILD | $27.11 B | 3,258,871.34% | ๐บ๐ธ USA |
Merck MRK | $60.11 B | 7,225,044.86% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $37.84 B | 4,549,004.04% | ๐ฌ๐ง UK |
Cleveland BioLabs
CBLI | $0.63 M | -24.06% | ๐บ๐ธ USA |
Arrowhead Pharmaceuticals
ARWR | $0.18 B | 21,743.46% | ๐บ๐ธ USA |